PGDip Cancer and Therapeutics in London United Kingdom | Queen Mary University of London

This program provides essential training in molecular and cellular biology, forming the basis for cancer biology and research. You'll explore cutting-edge advancements in cancer treatment, including innovative medications and genetic therapies, while learning how these new treatments are created, tested, and put into practice. Taught by specialists from Barts Cancer Institute—a key member of the Cancer Research UK City of London Centre, a globally recognized hub for cancer biotherapeutics—this program offers flexible part-time study options to accommodate your schedule. It delivers comprehensive training in cancer therapy while allowing for specialization, serving as an excellent career advancement opportunity in developing and applying new treatments. What you'll study This program offers in-depth knowledge of the scientific foundations behind cancer therapies. You'll learn the processes behind treatment development, assessment, and implementation. Upon completion, you'll gain expertise in cancer biology, pathology, research methods, drug discovery, and regulatory frameworks. You'll develop strong skills in evaluating cancer treatments, boosting your career opportunities in cancer research, early-stage clinical trials, and related fields. The program is led by Barts Cancer Institute, a Cancer Research UK Centre of Excellence and a core partner in the Cancer Research UK City of London Centre.